Researchers are exploring an epitope editing strategy that may enable less toxic stem cell transplants. This approach could potentially allow for non-genotoxic transplantation and in vivo cell selection, and may also make chemotherapy-free bone marrow transplants possible. The specifics of the research and its applications are still emerging, with various studies and collaborations underway to further develop this technology.